Send Inquiry
Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle foun d in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.Bortezomib
2016-09-10 04:40 Views:215
Price:Negotiable
Contact Infomation
Send Inquiry
Company name:Wuhan Newbio Pharm-tech Co., Ltd.
Status:[Offline] [Send message] [Chat]
Business contact:newbio(Ms.)
Telphone:
Mobile:
Fax:
Area: Caribbean Region-Bermuda
Address:858, East Lake, High-Tech Development Zone, Wuhan, Hubei, China
Zip:430075
Email:
Status:[Offline] [Send message] [Chat]
Business contact:newbio(Ms.)
Telphone:
Mobile:
Fax:
Area: Caribbean Region-Bermuda
Address:858, East Lake, High-Tech Development Zone, Wuhan, Hubei, China
Zip:430075
Email: